Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
For bacteria that secrete toxins, or harmful chemicals, a toxoid vaccine might be the answer. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, are safe for use in vaccines.
When the immune system receives a vaccine containing a harmless toxoid, it learns how to fight off the natural toxin. The immune system produces antibodies that lock onto and block the toxin. Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Toxoid Vaccines market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Toxoid Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Toxoid Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Astellas Pharma
Emergent Biosolutions
Valeant Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Shenzhen Kangtai Biological Products
Pfizer
Sanofi Pasteur
Bharat Biotech
Panacea Biotec
Merck
By Type:
Monovalent Tetanus Toxoid (TT)
Diphtheria
Tetanus
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
By End-User:
Hospitals And Clinics
Government Organizations
Research
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Toxoid Vaccines Market
-
1.3 Market Segment by Type
-
1.3.1 China Toxoid Vaccines Market Size and Growth Rate of Monovalent Tetanus Toxoid (TT) from 2016 to 2027
-
1.3.2 China Toxoid Vaccines Market Size and Growth Rate of Diphtheria from 2016 to 2027
-
1.3.3 China Toxoid Vaccines Market Size and Growth Rate of Tetanus from 2016 to 2027
-
1.3.4 China Toxoid Vaccines Market Size and Growth Rate of Pertussis (DTaP) from 2016 to 2027
-
1.3.5 China Toxoid Vaccines Market Size and Growth Rate of Diphtheria and Tetanus (DT) from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Toxoid Vaccines Market Size and Growth Rate of Hospitals And Clinics from 2016 to 2027
-
1.4.2 China Toxoid Vaccines Market Size and Growth Rate of Government Organizations from 2016 to 2027
-
1.4.3 China Toxoid Vaccines Market Size and Growth Rate of Research from 2016 to 2027
-
1.4.4 China Toxoid Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Toxoid Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Toxoid Vaccines by Major Types
-
3.4.1 Market Size and Growth Rate of Monovalent Tetanus Toxoid (TT)
-
3.4.2 Market Size and Growth Rate of Diphtheria
-
3.4.3 Market Size and Growth Rate of Tetanus
-
3.4.4 Market Size and Growth Rate of Pertussis (DTaP)
-
3.4.5 Market Size and Growth Rate of Diphtheria and Tetanus (DT)
4 Segmentation of Toxoid Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Toxoid Vaccines by Major End-Users
-
4.4.1 Market Size and Growth Rate of Toxoid Vaccines in Hospitals And Clinics
-
4.4.2 Market Size and Growth Rate of Toxoid Vaccines in Government Organizations
-
4.4.3 Market Size and Growth Rate of Toxoid Vaccines in Research
-
4.4.4 Market Size and Growth Rate of Toxoid Vaccines in Others
5 Market Analysis by Regions
-
5.1 China Toxoid Vaccines Production Analysis by Regions
-
5.2 China Toxoid Vaccines Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Toxoid Vaccines Landscape Analysis
-
6.1 North China Toxoid Vaccines Landscape Analysis by Major Types
-
6.2 North China Toxoid Vaccines Landscape Analysis by Major End-Users
7 Central China Toxoid Vaccines Landscape Analysis
-
7.1 Central China Toxoid Vaccines Landscape Analysis by Major Types
-
7.2 Central China Toxoid Vaccines Landscape Analysis by Major End-Users
8 South China Toxoid Vaccines Landscape Analysis
-
8.1 South China Toxoid Vaccines Landscape Analysis by Major Types
-
8.2 South China Toxoid Vaccines Landscape Analysis by Major End-Users
9 East China Toxoid Vaccines Landscape Analysis
-
9.1 East China Toxoid Vaccines Landscape Analysis by Major Types
-
9.2 East China Toxoid Vaccines Landscape Analysis by Major End-Users
10 Northeast China Toxoid Vaccines Landscape Analysis
-
10.1 Northeast China Toxoid Vaccines Landscape Analysis by Major Types
-
10.2 Northeast China Toxoid Vaccines Landscape Analysis by Major End-Users
11 Southwest China Toxoid Vaccines Landscape Analysis
-
11.1 Southwest China Toxoid Vaccines Landscape Analysis by Major Types
-
11.2 Southwest China Toxoid Vaccines Landscape Analysis by Major End-Users
12 Northwest China Toxoid Vaccines Landscape Analysis
-
12.1 Northwest China Toxoid Vaccines Landscape Analysis by Major Types
-
12.2 Northwest China Toxoid Vaccines Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Astellas Pharma
-
13.1.1 Astellas Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Emergent Biosolutions
-
13.2.1 Emergent Biosolutions Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Valeant Pharmaceuticals
-
13.3.1 Valeant Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 AstraZeneca
-
13.4.1 AstraZeneca Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 GlaxoSmithKline
-
13.5.1 GlaxoSmithKline Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Shenzhen Kangtai Biological Products
-
13.6.1 Shenzhen Kangtai Biological Products Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Pfizer
-
13.7.1 Pfizer Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Sanofi Pasteur
-
13.8.1 Sanofi Pasteur Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Bharat Biotech
-
13.9.1 Bharat Biotech Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Panacea Biotec
-
13.10.1 Panacea Biotec Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Merck
-
13.11.1 Merck Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Monovalent Tetanus Toxoid (TT) from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Diphtheria from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Tetanus from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Pertussis (DTaP) from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Diphtheria and Tetanus (DT) from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Hospitals And Clinics from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Government Organizations from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Research from 2016 to 2027
-
Figure China Toxoid Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Toxoid Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Toxoid Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Toxoid Vaccines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Toxoid Vaccines by Different Types from 2016 to 2027
-
Table Consumption Share of Toxoid Vaccines by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monovalent Tetanus Toxoid (TT)
-
Figure Market Size and Growth Rate of Diphtheria
-
Figure Market Size and Growth Rate of Tetanus
-
Figure Market Size and Growth Rate of Pertussis (DTaP)
-
Figure Market Size and Growth Rate of Diphtheria and Tetanus (DT)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Toxoid Vaccines by Different End-Users from 2016 to 2027
-
Table Consumption Share of Toxoid Vaccines by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals And Clinics
-
Figure Market Size and Growth Rate of Government Organizations
-
Figure Market Size and Growth Rate of Research
-
Figure Market Size and Growth Rate of Others
-
Table China Toxoid Vaccines Production by Regions
-
Table China Toxoid Vaccines Production Share by Regions
-
Figure China Toxoid Vaccines Production Share by Regions in 2016
-
Figure China Toxoid Vaccines Production Share by Regions in 2021
-
Figure China Toxoid Vaccines Production Share by Regions in 2027
-
Table China Toxoid Vaccines Consumption by Regions
-
Table China Toxoid Vaccines Consumption Share by Regions
-
Figure China Toxoid Vaccines Consumption Share by Regions in 2016
-
Figure China Toxoid Vaccines Consumption Share by Regions in 2021
-
Figure China Toxoid Vaccines Consumption Share by Regions in 2027
-
Table North China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table North China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure North China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure North China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure North China Toxoid Vaccines Consumption Share by Types in 2027
-
Table North China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table North China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure North China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure North China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure North China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table Central China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table Central China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Central China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure Central China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure Central China Toxoid Vaccines Consumption Share by Types in 2027
-
Table Central China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table Central China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure Central China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure Central China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table South China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table South China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure South China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure South China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure South China Toxoid Vaccines Consumption Share by Types in 2027
-
Table South China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table South China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure South China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure South China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure South China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table East China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table East China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure East China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure East China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure East China Toxoid Vaccines Consumption Share by Types in 2027
-
Table East China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table East China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure East China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure East China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure East China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table Northeast China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table Northeast China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure Northeast China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure Northeast China Toxoid Vaccines Consumption Share by Types in 2027
-
Table Northeast China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northeast China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure Northeast China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure Northeast China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table Southwest China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table Southwest China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure Southwest China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure Southwest China Toxoid Vaccines Consumption Share by Types in 2027
-
Table Southwest China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table Southwest China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure Southwest China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure Southwest China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table Northwest China Toxoid Vaccines Consumption by Types from 2016 to 2027
-
Table Northwest China Toxoid Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Toxoid Vaccines Consumption Share by Types in 2016
-
Figure Northwest China Toxoid Vaccines Consumption Share by Types in 2021
-
Figure Northwest China Toxoid Vaccines Consumption Share by Types in 2027
-
Table Northwest China Toxoid Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northwest China Toxoid Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Toxoid Vaccines Consumption Share by End-Users in 2016
-
Figure Northwest China Toxoid Vaccines Consumption Share by End-Users in 2021
-
Figure Northwest China Toxoid Vaccines Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Emergent Biosolutions
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent Biosolutions
-
Figure Sales and Growth Rate Analysis of Emergent Biosolutions
-
Figure Revenue and Market Share Analysis of Emergent Biosolutions
-
Table Product and Service Introduction of Emergent Biosolutions
-
Table Company Profile and Development Status of Valeant Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals
-
Table Product and Service Introduction of Valeant Pharmaceuticals
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Shenzhen Kangtai Biological Products
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen Kangtai Biological Products
-
Figure Sales and Growth Rate Analysis of Shenzhen Kangtai Biological Products
-
Figure Revenue and Market Share Analysis of Shenzhen Kangtai Biological Products
-
Table Product and Service Introduction of Shenzhen Kangtai Biological Products
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Sanofi Pasteur
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur
-
Figure Sales and Growth Rate Analysis of Sanofi Pasteur
-
Figure Revenue and Market Share Analysis of Sanofi Pasteur
-
Table Product and Service Introduction of Sanofi Pasteur
-
Table Company Profile and Development Status of Bharat Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech
-
Figure Sales and Growth Rate Analysis of Bharat Biotech
-
Figure Revenue and Market Share Analysis of Bharat Biotech
-
Table Product and Service Introduction of Bharat Biotech
-
Table Company Profile and Development Status of Panacea Biotec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec
-
Figure Sales and Growth Rate Analysis of Panacea Biotec
-
Figure Revenue and Market Share Analysis of Panacea Biotec
-
Table Product and Service Introduction of Panacea Biotec
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
